)
)
Tom Lanz
Senior Director, Multi-Omics and Biomarkers
,
Pfizer
Tom Lanz is Senior Director of Multi-Omics and Biomarkers at Pfizer Drug Safety Research & Development. A neurobiologist by training, Tom brings over 20 years of experience in translational science, spanning Alzheimer’s and Parkinson’s disease, immunology, and toxicology.
He leads cross-functional teams applying cutting-edge omics technologies—including single-cell RNA-seq, proteomics, and analytics—to discover and validate biomarkers across therapeutic areas.
Tom is passionate about bridging experimental and computational biology to accelerate biomarker innovation and improve patient outcomes.
Sessions
-
Multi-Omic Case Studies in Drug Safety: Biomarker Discovery and Mechanistic Insights03-Jun-2026Multi-Omics Integration Stage